Gossamer Bio, Inc. (GOSS)
0.3627
-0.01
(-2.92%)
USD |
NASDAQ |
Apr 24, 16:00
0.362
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Profit Margin (Quarterly) : -342.3% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -246.8% |
| Artelo Biosciences, Inc. | -- |
| Arvinas, Inc. | -709.5% |
| Quince Therapeutics, Inc. | -- |
| Vir Biotechnology, Inc. | -66.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -69.95% |
| Return on Invested Capital | -108.3% |
| Gross Profit Margin (Quarterly) | 98.36% |
| Operating Margin (Quarterly) | -333.6% |
| Return on Net Operating Assets | -1.33K% |